JPMorgan analyst Anupam Rama established a $9 December 2025 price target on shares of Sage Therapeutics (SAGE) while keeping a Neutral rating ...
Roche Holding AG Akt 0.83% CHF240.89B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback